Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SPTX

Seaport Therapeutics Inc

May 05 • 04:00PM ET

16.00

-1.00 -5.88 %

Healthcare • Biotechnology • USA • Small • NASD

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	53.03M	Perf Week	-
Market Cap	839.04M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-19.35%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	23.00 -30.43%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	16.90 -5.33%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	3.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	-9.16%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-9.16%	Rel Volume	0.32	Prev Close	17.00
Employees	54	LT Debt/Eq	-	Earnings	-	SMA200	-9.16%	Avg Volume	2.80M	Price	16.00
IPO	May 01, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	892,147	Change	-5.88%

Seaport Therapeutics, Inc. is a clinical-stage therapeutics company, which engages in the provision of inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company was founded on April 1, 2024 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ARCH Venture Partners XII, LLC	10% Owner	May 04 '26	Buy	18.00	1,100,000	19,800,000	6,294,951	May 04 06:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SPTX

Seaport Therapeutics Inc

Upgrade your Finviz experience